Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a seizure medication boost memory in Alzheimer's patients?

NCT ID NCT05899764

First seen Feb 01, 2026 · Last updated May 20, 2026 · Updated 14 times

Summary

This study looks at whether the seizure drug brivaracetam can calm overactive brain activity in people with mild Alzheimer's or mild cognitive impairment. Researchers will place tiny electrodes in the brain to measure abnormal electrical signals. The goal is to see if reducing these signals can improve memory and thinking over 3 to 12 months. About 25 adults aged 45 to 70 will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mary S. Easton Center for Alzheimer's Research and Care

    Los Angeles, California, 90095-1769, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.